ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,996,000 | -22.5% | 346,842 | -69.0% | 0.34% | -78.8% |
| Q2 2019 | $29,689,000 | +5.9% | 1,120,346 | -26.7% | 1.59% | -17.1% |
| Q1 2019 | $28,043,000 | -57.5% | 1,528,213 | -71.3% | 1.91% | -68.9% |
| Q4 2018 | $66,027,000 | -54.7% | 5,316,156 | -30.1% | 6.15% | -29.6% |
| Q3 2018 | $145,773,000 | +29.1% | 7,604,225 | -8.4% | 8.73% | +7.2% |
| Q2 2018 | $112,874,000 | +436.8% | 8,299,542 | +184.6% | 8.14% | +306.8% |
| Q1 2018 | $21,028,000 | +156.2% | 2,916,561 | +161.2% | 2.00% | -19.3% |
| Q3 2016 | $8,208,000 | – | 1,116,777 | – | 2.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |